Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,052 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Alcohol consumption, multiple Lugol-voiding lesions, and field cancerization.
Katada C, Yokoyama T, Yano T, Suzuki H, Furue Y, Yamamoto K, Doyama H, Koike T, Tamaoki M, Kawata N, Hirao M, Kawahara Y, Ogata T, Katagiri A, Yamanouchi T, Kiyokawa H, Kawakubo H, Konno M, Yokoyama A, Ohashi S, Kondo Y, Kishimoto Y, Kano K, Mure K, Hayashi R, Ishikawa H, Yokoyama A, Muto M. Katada C, et al. Among authors: ogata t. DEN Open. 2023 Jul 3;4(1):e261. doi: 10.1002/deo2.261. eCollection 2024 Apr. DEN Open. 2023. PMID: 37409321 Free PMC article. Review.
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma.
Doki Y, Ajani JA, Kato K, Xu J, Wyrwicz L, Motoyama S, Ogata T, Kawakami H, Hsu CH, Adenis A, El Hajbi F, Di Bartolomeo M, Braghiroli MI, Holtved E, Ostoich SA, Kim HR, Ueno M, Mansoor W, Yang WC, Liu T, Bridgewater J, Makino T, Xynos I, Liu X, Lei M, Kondo K, Patel A, Gricar J, Chau I, Kitagawa Y; CheckMate 648 Trial Investigators. Doki Y, et al. Among authors: ogata t. N Engl J Med. 2022 Feb 3;386(5):449-462. doi: 10.1056/NEJMoa2111380. N Engl J Med. 2022. PMID: 35108470 Clinical Trial.
The C-reactive Protein to Prealbumin Ratio Is an Independent Prognostic Factor for Patients With Gastric Cancer Who Receive Curative Surgery.
Aoyama T, Hashimoto I, Maezawa Y, Hara K, Komori K, Otani K, Kazama K, Sawazaki S, Numata M, Kamiya N, Kato A, Yamada T, Nagasawa S, Kawahara S, Cho H, Morita J, Tanabe M, Yukawa N, Saito A, Rino Y, Ogata T, Oshima T. Aoyama T, et al. Among authors: ogata t. Anticancer Res. 2023 Nov;43(11):5181-5187. doi: 10.21873/anticanres.16719. Anticancer Res. 2023. PMID: 37909998
Comparison of Dietary Intake After Gastric Cancer Gastrectomy Between Patients With and Without Postoperative Surgical Complications.
Tanabe M, Aoyama T, Nakazono M, Morita J, Otani K, Oonuma S, Kawahara S, Hashimoto I, Komori K, Hara K, Kanematsu K, Nagasawa S, Kato A, Maezawa Y, Yamada T, Cho H, Yukawa N, Ogata T, Rino Y, Saito A, Oshima T. Tanabe M, et al. Among authors: ogata t. Anticancer Res. 2024 Feb;44(2):839-844. doi: 10.21873/anticanres.16876. Anticancer Res. 2024. PMID: 38307558
A propensity‑matched analysis of the prognostic value of advanced lung cancer inflammation index in patients with gastric cancer after curative resection.
Hashimoto I, Tanabe M, Onuma S, Morita J, Nagasawa S, Maezawa Y, Kanematsu K, Aoyama T, Yamada T, Ogata T, Yukawa N, Rino Y, Saito A, Oshima T. Hashimoto I, et al. Among authors: ogata t. Oncol Lett. 2024 Apr 26;27(6):285. doi: 10.3892/ol.2024.14418. eCollection 2024 Jun. Oncol Lett. 2024. PMID: 38736744 Free PMC article.
Nivolumab plus chemotherapy or ipilimumab versus chemotherapy in patients with advanced esophageal squamous cell carcinoma (CheckMate 648): 29-month follow-up from a randomized, open-label, phase III trial.
Kato K, Doki Y, Chau I, Xu J, Wyrwicz L, Motoyama S, Ogata T, Kawakami H, Hsu CH, Adenis A, El Hajbi F, Di Bartolomeo M, Braghiroli MI, Holtved E, Makino T, Blum Murphy M, Amaya-Chanaga C, Patel A, Hu N, Matsumura Y, Kitagawa Y, Ajani J. Kato K, et al. Among authors: ogata t. Cancer Med. 2024 May;13(9):e7235. doi: 10.1002/cam4.7235. Cancer Med. 2024. PMID: 38716626 Free PMC article. Clinical Trial.
2,052 results